Dr. David Chism MD

Media Releases

Enhancing Cancer Patient Outcomes with Molecular Biology Advances and Novel Therapeutics

Knoxville, Tennessee - Dr. David Chism, a distinguished board-certified medical oncologist and hematologist, is spearheading groundbreaking advancements in cancer research as the Medical Director of Clinical Research at Thompson Cancer Survival Center, a part of Covenant Health. With a strong focus on genitourinary malignancies, Dr. Chism leads a proficient team of professionals dedicated to designing, implementing, and evaluating clinical trials and correlative science studies for cancer patients.

Dr. Chism brings over four years of outstanding experience to his role as the Medical Director of Clinical Research, where he provides expert medical direction, strategic guidance, and meticulous oversight for the oncology clinical research program. His unwavering commitment ensures that the program maintains the highest standards of quality, safety, and compliance with regulatory and ethical protocols.

Having received comprehensive education and training from esteemed institutions such as Georgetown University, Tulane University, the University of North Carolina Hospitals, and Rutgers Health/Robert Wood Johnson Medical School, Dr. Chism’s expertise is further validated by his board certification in medical oncology by the American Board of Internal Medicine.

As a member of various prestigious organizations such as  the Thompson Cancer Survival Center/Thompson Oncology Group, the American Society of Clinical Oncology (ASCO), and NRG Oncology, Dr. Chism actively engages in cutting-edge research and medical education initiatives. His passion for advancing oncology is evident through his extensive contributions to publications, presentations, and grants in the field.  He currently serves as Editor-elect for the ASCO national publication State of Cancer Care in America. 

Noteworthy accolades adorn Dr. Chism’s illustrious career, including Resident Travel Award from the American Society of Clinical Oncology, Clinical Oncology Merit Award from the American Society of Clinical Oncology, Leadership developmental program member from the American Society of Clinical Oncology and multiple recognitions as a Top Doctor for Medical Oncology by Castle Connolly, among other honors. 

Dr. Chism’s mission is to leverage the latest developments in molecular biology and novel therapeutics to enhance the outcomes and quality of life for cancer patients. His innovative approach and dedication to excellence continue to inspire hope and transform the landscape of cancer care at Thompson Cancer Survival Center.

Recommended Articles

• New Combination Therapy for Hodgkin's Lymphoma Shows Promising Results

  While there are several different types of Hodgkin’s lymphoma, more than 80% of cases of diagnosed lymphoma are non-Hodgkin’s lymphoma. Patients with non-Hodgkin’s lymphoma typically receive radiation therapy, chemotherapy, or combinations of the two. Stem cell or bone marrow transplantations...

• Alternative Treatment for Prostate Cancer

  Prostate cancer has become a common disease in men, especially those aged from 50 years and above. Having prostate cancer comes with its own effects that no one wants to be part of. Various symptoms accompany an affected prostate gland. Such symptoms may include pain when urinating, high frequency...

• How to Sort Out Financial Challenges of Breast Cancer

  When a woman faces breast cancer, she should only have to worry about one thing: recovery. But the cold hard truth is that many women must face the reality financial hardship during an already tumultuous time. The outcomes of bankruptcy, welfare, and losing the family home are not usually what we...

• Comparing Male and Female Breast Cancer

  All individuals are born with certain breast cells and tissue. Even though men do not have milk-producing breasts, they can still get cancer. Nonetheless, breast cancer is 100x less common among men then it is among women. The American Cancer Society estimates for breast cancer in the United States...

• What Causes Lung Cancer?

  Lung cancer is the unsuppressed growth of cells in the tissues of the lungs. Such a condition leads to a tumor (malignant) which may spread (by metastasis) to different organs of the body if not treated in time. Cancer of the lung at the primary stage is also known as carcinoma. The two types of...

• Can Multiple Myeloma be Asymptomatic?

  Early treatment for persons suffering from multiple myeloma that is asymptomatic may not be beneficial. The initial stages for multiple myeloma do not show symptoms, and this is known as being asymptomatic.The treatment for persons with asymptomatic multiple myeloma should be deferred up to when the...